Randomized Clinical Trial to Evaluate the Regenerative Capacity of CardioCell in Patients With Chronic Ischaemic Heart Failure (CIHF)

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 115 participants.

Also called NCT03418233

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2/3
Enrolled
  • 115 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03418233
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Poland (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03418233. Randomized; quadruple masking; primary purpose treatment. Start 2018-04-19 (actual); primary completion 2021-01-27 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Randomized Clinical Trial to Evaluate the Regenerative Capacity of CardioCell in Patients With Chronic Ischaemic Heart Failure (CIHF)
Condition
Heart Failure
Intervention (Drug)
CardioCell
Intervention (Drug)
Placebos
Lead sponsor
John Paul II Hospital, Krakow (class: other)
Collaborator
KCRI (class: other)
Collaborator
National Center for Research and Development, Poland (class: other)

Record details

Record id
cardio:ct-nct03418233
Content hash
4bbd02f38e6dd0dcad4c04f9db6022521995803f549a6d0c483844824d33a253